<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>272957</rcn>
  <id>101210115</id>
  <acronym>PROTONIX</acronym>
  <teaser>Cancer and cardiovascular diseases are the leading causes of death in the EU, resulting in 54% of deaths in 2021. There is an urgent need for more effective therapeutics for these diseases, but drug discovery is slow, taking 16 to 20 years from target identification to drug...</teaser>
  <objective>Cancer and cardiovascular diseases are the leading causes of death in the EU, resulting in 54% of deaths in 2021. There is an urgent need for more effective therapeutics for these diseases, but drug discovery is slow, taking 16 to 20 years from target identification to drug approval.

To accelerate drug discovery, pharmaceutical companies use computational tools. Among the most successful are physical molecular simulations, which are limited by the availability of experimental structural data. A new generation of machine learning (ML) powered structure prediction tools, such as AlphaFold, offer the potential to supply structural data suitable for physics-based modeling without the need to experimentally solve structures. However, these tools produce 3D structures missing key physical details, which are vital for accurate molecular modeling. A critical physical detail is the assignment of relevant protein protonation states, where misprediction results in large errors in drug binding affinity predictions, slowing down drug discovery. 

PROTONIX will bridge this gap between physical molecular simulations and ML structure prediction tools to improve the speed and accuracy of computational drug discovery, by adding protonation details to structure predictions. I will focus on the human kinase superfamily, the main therapeutic target class for cancer and cardiovascular diseases. PROTONIX will contain two open-source ML models. First, PROTONFOLD will use a diffusion model to predict relevant protonation states with their corresponding proton positions from ML protein structure predictions, generating simulation-ready files. Second, PROTONCON will use a flow-matching model to integrate protonation state prediction with multiconformer protein structure generation, providing insights into the coupling between protonation states and protein conformations. PROTONIX will point the way for future AlphaFold-like models to produce structures immediately useful for drug discovery.</objective>
  <title>Bridging protein structure prediction with molecular simulations via diffusion models for missing protonation states</title>
  <totalCost>0</totalCost>
  <ecMaxContribution>202125.12</ecMaxContribution>
  <startDate>2026-01-01</startDate>
  <endDate>2027-12-31</endDate>
  <ecSignatureDate>2025-04-10</ecSignatureDate>
  <duration>24</duration>
  <status>SIGNED</status>
  <keywords>Protonation state effects, kinases, protein structure prediction, computational drug design,  generative modeling, diffusion models, protein conformer generation, constant-pH molecular dynamics</keywords>
  <identifiers>
    <grantDoi>10.3030/101210115</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-04-15 01:21:47</sourceUpdateDate>
  <contentCreationDate>2025-06-05 16:18:56</contentCreationDate>
  <contentUpdateDate>2025-06-05 16:18:54</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:53</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>56116</rcn>
        <title>HORIZON-MSCA-2024-PF-01</title>
        <identifier>HORIZON-MSCA-2024-PF-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>56116</rcn>
        <title>HORIZON-MSCA-2024-PF-01</title>
        <identifier>HORIZON-MSCA-2024-PF-01</identifier>
      </call>
      <organization netEcContribution="0" totalCost="0" source="corda" order="2" terminated="false" sme="false" type="associatedPartner">
        <availableLanguages>en</availableLanguages>
        <rcn>1931333</rcn>
        <id>988105924</id>
        <legalName>Sloan-Kettering Institute for Cancer Research CORPORATION</legalName>
        <address>
          <street>York Avenue  1275</street>
          <city>New York</city>
          <postalCode>10065</postalCode>
          <country>US</country>
          <geolocation>40.76445335,-73.956944078471</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>United States</name>
              <rcn>510822952</rcn>
              <nutsCode>US</nutsCode>
              <euCode>US</euCode>
              <isoCode>US</isoCode>
            </region>
            <region type="relatedRegion">
              <name>United States</name>
              <rcn>510822952</rcn>
              <nutsCode>US</nutsCode>
              <euCode>US</euCode>
              <isoCode>US</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="202125.12" totalCost="0" source="corda" order="1" ecContribution="202125.12" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1907989</rcn>
        <id>999994826</id>
        <vatNumber>DE811304768</vatNumber>
        <legalName>FREIE UNIVERSITAET BERLIN</legalName>
        <shortName>Freie Universitaet Berlin</shortName>
        <address>
          <street>KAISERSWERTHER STRASSE 16-18</street>
          <city>BERLIN</city>
          <postalCode>14195</postalCode>
          <country>DE</country>
          <postBox>N/A</postBox>
          <url>http://www.fu-berlin.de</url>
          <geolocation>52.4479315,13.2857452529264</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Berlin</name>
              <rcn>221786112</rcn>
              <nutsCode>DE300</nutsCode>
              <parents>
                <region>
                  <name>Berlin</name>
                  <rcn>221786152</rcn>
                  <nutsCode>DE30</nutsCode>
                  <parents>
                    <region>
                      <name>Berlin</name>
                      <rcn>221788712</rcn>
                      <nutsCode>DE3</nutsCode>
                      <parents>
                        <region>
                          <name>Germany</name>
                          <rcn>221940264</rcn>
                          <nutsCode>DE</nutsCode>
                          <euCode>DE</euCode>
                          <isoCode>DE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Germany</name>
              <rcn>221940264</rcn>
              <nutsCode>DE</nutsCode>
              <euCode>DE</euCode>
              <isoCode>DE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705729</rcn>
        <id>HORIZON.1.2</id>
        <code>HORIZON.1.2</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.2</pga>
        <title>Marie Skłodowska-Curie Actions (MSCA)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>708088</rcn>
        <id>HORIZON_HORIZON-MSCA-2024-PF-01-01</id>
        <code>HORIZON-MSCA-2024-PF-01-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>MSCA Postdoctoral Fellowships 2024</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/315/997/1613</code>
        <title>proteins</title>
        <displayCode>/natural sciences/biological sciences/biochemistry/biomolecules/proteins</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode>/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-TMA-MSCA-PF-EF</code>
        <title>HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</title>
        <description>HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</description>
        <displayCode>/HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>